Abstract
As the largest organ in the body, the skin may reveal the first manifestations of internal disease. The astute clinician can often use dermatologic findings to diagnose an underlying systemic disease. This chapter outlines some of the most important skin manifestations of internal disease. Common yet clinically important systemic diseases will be reviewed, and their most notable skin findings will be delineated.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Massengale WT, Nesbitt Jr LT. Xanthomas. In: Bolognia JL et al., editors. Dermatology. New York: Mosby; 2003. p. 1448.
Naik NS. Eruptive xanthomas. Dermatol Online J. 2001;7:11.
Cohen P. Xanthelasma palpebrarum. J Gt Houst Dent Soc. 1996;67:10.
Bergman R. The pathogenesis and clinical significance of xanthelasma palpebrarum. J Am Acad Dermatol. 1994;30:236.
Pedace FJ, Winkelmann RK. Xanthelasma palpebrarum. JAMA. 1965;193:893.
Merola JF, Mengden SJ, Soldano A, Rosenman K. Eruptive xanthomas. Dermatol Online J. 2008;14(5):10.
Park EJ, Youn SH, Cho EB, Lee GS, Hann SK, Kim KH, Kim KJ. Xanthelasma palpebrarum treatment with a 1,450-nm-diode laser. Dermatol Surg. 2011. doi 10.1111/j.1524-4725.2011.01945.x. [Epub ahead of print].
Mendelson BC, Masson JK. Xanthelasma: follow-up on results after surgical excision. Plast Reconstr Surg. 1976;58:535.
Muehrcke RC. The fingernails in chronic hypoalbuminaemia: a new physical sign. BMJ. 1956;9:1327–8.
Lindsay PG. The half-and-half nail. Arch Intern Med. 1967;119:583–7.
Leyden JJ, Wood MG. The half and half nail: a Âuremic onychopathology. Arch Dermatol. 1972;105:591–2.
Kint A, Bussels L, Fernandes M, Ringoir S. Skin and nail disorders in relation to chronic renal failure. Acta Derm Venerol. 1974;54:137–40.
Goicoechea M, de Sequera P, Ochando A, et al. Uremic pruritus: an unresolved problem in hemodialysis patients. Nephron. 1999;82:73–4.
Urbonas A, Schwartz RA, Szepietowski JC. Uremic pruritus: an update. Am J Nephrol. 2001;21:343–50.
Walsh SR, Parada NA. Uremic frost. N Eng J Med. 2005;352:e13.
Kuo CC, Hung JB, Tsai CW, Chen YM. Uremic frost. CMAJ. 2010;182(17):E800. Epub 2010.
Lowitt MH, Dover JS. Necrobiosis lipoidica. J Am Acad Dermatol. 1991;25:735.
Muller SAK, Winkelman RK. Necrobiosis lipoidica diabeticorum: a clinical and pathological investigation of 171 cases. Arch Dermatol. 1966;93(3):272–81.
Suzuki K, Ito Y, Nakamura S, Ochiai J, Aoki K. Relationship between serum carotenoids and hyperglycemia: a population-based crosssectional study. J Epidemiol. 2002;12:357–66.
Huntley AC. Cutaneous manifestations of diabetes mellitus. Dermatol Clin. 1989;7:531–46.
Wahid Z, Kanjee A. Cutaneous manifestations of diabetes mellitus. J Pak Med Assoc. 1998;48:304–5.
Lipsky BA, Baker PD, Ahroni JH. Diabetic bullae: 12 cases of a purportedly rare cutaneous disorder. Int J Dermatol. 2000;39:196–200.
Aye M, Masson EA. Dermatological care of the diabetic foot. Am J Clin Dermatol. 2002;3:463–74.
Bolognia JL, Jorizzo JL, Rapini RP. Other vesiculobullous diseases. In: Dermatology, 1st ed. Philadelphia, PA: Mosby, 2003. pp 501–8.
Lopez PR, Leicht S, Sigmon JR, Stigall L. Bullosis diabeticorum associated with a prediabetic state. South Med J. 2009;102(6):643–4.
Hermanns-Le T, Scheen A, Pierard GE. Acanthosis nigricans associated with insulin resistance: pathophysiology and management. Am J Clin Dermatol. 2004;5:199–203.
Ai J, Leonhardt JM, Heymann WR. Autoimmune thyroid diseases: etiology, pathogenesis, and dermatologic manifestations. J Am Acad Dermatol. 2003;48:641–59.
Daumerie C, Ludgate M, Costagliola S, Many MC. Evidence of thyrotropin receptor immunoreactivity in pretibial connective tissue from patients with thyroid-associated dermopathy. Eur J Endocrinol. 2002;146:35–8.
Rosen T, Kleman GA. Thyroid and the skin. In: Callen JP et al., editors. Dermatological signs of internal disease. Philadelphia, PA: W.B. Saunders; 1995. p. 189–95.
Yanardag H, Pamuk ON, Karayel T. Cutaneous involvement in sarcoidosis: analysis of the features in 170 patients. Respir Med. 2003;97:978–82.
Callen JP. Sarcoidosis. In: Callen JP et al., editors. Dermatological signs of internal disease. Philadelphia, PA: W.B. Saunders; 1995. p. 293–300.
Leonard AL. Sarcoidosis. Dermatol Online J. 2003;9:40.
Kunz M, Beutel S, Brocker E. Leukocyte activation in erythema nodosum. Clin Exp Dermatol. 1999;24:396–401.
Baughman RP, Lower EE. Newer therapies for cutaneous sarcoidosis: the role of thalidomide and other agents. Am J Clin Dermatol. 2004;5:385–94.
Feldman SR. Adrenal, androgen-related, and pituitary disorders. In: Callen JP et al., editors. Dermatological signs of internal disease. Philadelphia, PA: W.B. Saunders; 1995. p. 203–11.
Freinkel RK. Other endocrine diseases. In: Freedberg IM et al., editors. Fitzpatrick’s dermatology in general medicine. New York: McGraw-Hill; 1999. p. 1980–1.
Ohnishi T, et al. Erythrodermic psoriasis associated with hyperuricemia and iatrogenic Cushing’s syndrome due to topical corticosteroid therapy. Int J Dermatol. 1996;35(5):379–80.
Tosti A, Iorizzo M, Piraccini BM, Starace M. The nail in systemic diseases. Dermatol Clin. 2006;24:341–7.
Martinez-Lavin M, Vargas A, Rivera-Viñas M. Hypertrophic osteoarthropathy: a palindrome with a pathogenic connotation. Curr Opin Rheumatol. 2008;20:88–91.
Tosti A, Piraccini BM, Iorizzo M. Systemic itraconazole in the yellow nail syndrome. Br J Dermatol. 2002;146(6):1064–7.
Jorizzo JL, Greer KE, Callen JP. Miscellaneous disorders with prominent features involving the skin and the joints. In: Callen JP, Jorizzo JL, Bolognia JL, et al., editors. Dermatologic signs of internal disease. 3rd ed. Philadelphia, PA: W.B. Saunders; 2003. p. 39–41.
Beltraminelli HS, Buechner SA, Haeusermann P. Pancreatic panniculitis in a patient with an acinar cell cystadenocarcinoma of the pancreas. Dermatology. 2004;208:265–7.
Nikolas ME, Krause PK, Gibson LE, et al. Dermatits herpetiformis. Int J Dermatol. 2003;42:588–600.
Braverman IM. Disease of the gastrointestinal tract. Skin signs of systemic disease, 3rd ed. Philadelphia, PA: W.B. Saunders, 1998. pp. 405–37.
Holzberg M, Walker HK. Terry’s nails: revised definition and new correlations. Lancet. 1984;1:896–9.
Piette WW. Dysproteinemias, plasma cell disorders, and amyloidosis. In: Callen JP et al., editors. Dermatological signs of internal disease. Philadelphia, PA: W.B. Saunders; 1995. p. 137–49.
Silverstein SR. Primary, systemic amyloidosis and the dermatologist: where classic skin lesions may provide the clue for early diagnosis. Dermatol Online J. 2005;11:5.
Jambrosic J, from L, Hanna W. Lichen amyloidosis: Ultrastructure and pathogenesis. Am J Dermatopathol. 1984;6:151–8.
Albano EA, Kanter J. Images in clinical medicine. Sister Mary Joseph’s nodule. N Engl J Med. 2005;352(18):1913.
Carroll MC, Fleming M, Chitambar CR, Neuburg M. Diagnosis, workup, and prognosis of cutaneous metastases of unknown primary origin. Dermatol Surg. 2002;28:533–5.
Mekhail TM, Markman M. Acanthosis nigricans with endometrial carcinoma: case report and review of the literature. Gynecol Oncol. 2002;84:332–4.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2013 Springer Science+Business Media, LLC
About this chapter
Cite this chapter
Behroozan, D., Jeon, H. (2013). Skin Manifestations of Internal Disease. In: Buka, B., Uliasz, A., Krishnamurthy, K. (eds) Buka's Emergencies in Dermatology. Springer, New York, NY. https://doi.org/10.1007/978-1-4614-5031-3_10
Download citation
DOI: https://doi.org/10.1007/978-1-4614-5031-3_10
Published:
Publisher Name: Springer, New York, NY
Print ISBN: 978-1-4614-5030-6
Online ISBN: 978-1-4614-5031-3
eBook Packages: MedicineMedicine (R0)